Literature DB >> 20871424

Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny.

Leif-Erik Bohman1, Kristin R Swanson, Julia L Moore, Russ Rockne, Christopher Mandigo, Todd Hankinson, Marcela Assanah, Peter Canoll, Jeffrey N Bruce.   

Abstract

BACKGROUND: Identifying the origin of gliomas carries important implications for advancing the treatment of these recalcitrant tumors. Recent research promotes the hypothesis of a subventricular zone (SVZ) origin for the stemlike gliomagenic cells identified within human glioma specimens. However, conflicting evidence suggests that SVZ-like cells are not uniquely gliomagenic but this capacity may be shared by cycling progenitors distributed throughout the subcortical white matter (SCWM).
OBJECTIVE: To review radiological evidence in glioblastoma multiforme (GBM) patients to provide insight into the question of glioma ontogeny.
METHODS: We explored whether GBMs at first diagnosis demonstrated a pattern of anatomic distribution consistent with origin at the SVZ through retrospective analysis of preoperative contrast-enhanced T1-weighted magnetic resonance images in 63 patients. We then examined the relationship of tumor volume, point of origin, and proximity to the ventricles using a computer model of glioma growth.
RESULTS: Fewer than half of the GBMs analyzed had contrast-enhancing portions that contacted the ventricle on preoperative imaging. A strong correlation was found between tumor volume and the distance between the contrast-enhancing edge of the tumor and the ventricle, demonstrating that tumors abutting the ventricle are significantly larger than those that do not. The lesions simulated by the computer model validated our assumption that tumors that are radiographically distant from the ventricles are unlikely to have originated in the SVZ and supported our hypothesis that as they grow, the edges of all tumors will near the ventricles, regardless of their point of origin.
CONCLUSION: This work offers further support for the hypothesis that the origins of GBMs are at sites distributed throughout the white matter and are not limited to the region of the SVZ.

Entities:  

Mesh:

Year:  2010        PMID: 20871424      PMCID: PMC3774031          DOI: 10.1227/NEU.0b013e3181f556ab

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  34 in total

Review 1.  The evolution of mathematical modeling of glioma proliferation and invasion.

Authors:  Hana L P Harpold; Ellsworth C Alvord; Kristin R Swanson
Journal:  J Neuropathol Exp Neurol       Date:  2007-01       Impact factor: 3.685

2.  Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses.

Authors:  Marcela Assanah; Richard Lochhead; Alfred Ogden; Jeffrey Bruce; James Goldman; Peter Canoll
Journal:  J Neurosci       Date:  2006-06-21       Impact factor: 6.167

3.  Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter.

Authors:  N S Roy; S Wang; C Harrison-Restelli; A Benraiss; R A Fraser; M Gravel; P E Braun; S A Goldman
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

4.  In vitro identification and functional characterization of glial precursor cells in human gliomas.

Authors:  C Colin; N Baeza; S Tong; C Bouvier; B Quilichini; P Durbec; D Figarella-Branger
Journal:  Neuropathol Appl Neurobiol       Date:  2006-04       Impact factor: 8.090

5.  Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.

Authors:  Alfred T Ogden; Allen E Waziri; Richard A Lochhead; David Fusco; Kim Lopez; Jason A Ellis; Joann Kang; Marcela Assanah; Guy M McKhann; Michael B Sisti; Paul C McCormick; Peter Canoll; Jeffrey N Bruce
Journal:  Neurosurgery       Date:  2008-02       Impact factor: 4.654

6.  Relationship of gliomas to the ventricular walls.

Authors:  Kaveh Barami; Andrew E Sloan; Amyn Rojiani; Michael J Schell; Aileen Staller; Steven Brem
Journal:  J Clin Neurosci       Date:  2008-12-18       Impact factor: 1.961

Review 7.  Characterization of adult neural stem cells and their relation to brain tumors.

Authors:  Erica L Jackson; Arturo Alvarez-Buylla
Journal:  Cells Tissues Organs       Date:  2008-01-28       Impact factor: 2.481

8.  Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model.

Authors:  Sheila Alcantara Llaguno; Jian Chen; Chang-Hyuk Kwon; Erica L Jackson; Yanjiao Li; Dennis K Burns; Arturo Alvarez-Buylla; Luis F Parada
Journal:  Cancer Cell       Date:  2009-01-06       Impact factor: 31.743

9.  Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype.

Authors:  Daniel A Lim; Soonmee Cha; Mary C Mayo; Mei-Hsiu Chen; Evren Keles; Scott VandenBerg; Mitchel S Berger
Journal:  Neuro Oncol       Date:  2007-07-10       Impact factor: 12.300

10.  A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle.

Authors:  K R Swanson; R C Rostomily; E C Alvord
Journal:  Br J Cancer       Date:  2007-12-04       Impact factor: 7.640

View more
  32 in total

Review 1.  Stem cell niche irradiation in glioblastoma: providing a ray of hope?

Authors:  Tejpal Gupta; Vimoj Nair; Rakesh Jalali
Journal:  CNS Oncol       Date:  2014

2.  Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.

Authors:  Tyler C Steed; Jeffrey M Treiber; Birra Taha; H Billur Engin; Hannah Carter; Kunal S Patel; Anders M Dale; Bob S Carter; Clark C Chen
Journal:  J Neurooncol       Date:  2020-06-15       Impact factor: 4.130

3.  Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?

Authors:  Sheng Han; Xiang Li; Bo Qiu; Tao Jiang; Anhua Wu
Journal:  J Neurooncol       Date:  2015-05-26       Impact factor: 4.130

4.  A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma.

Authors:  Chul-Kee Park; Jeong Hoon Kim; Do-Hyun Nam; Chae-Yong Kim; Sang-Bong Chung; Young-Hoon Kim; Ho Jun Seol; Tae Min Kim; Seung Hong Choi; Se-Hoon Lee; Dae Seog Heo; Il Han Kim; Dong Gyu Kim; Hee-Won Jung
Journal:  Neuro Oncol       Date:  2013-06-25       Impact factor: 12.300

5.  MADM gives new insights into gliomagenesis.

Authors:  Liang Lei; Peter Canoll
Journal:  J Mol Cell Biol       Date:  2011-09-15       Impact factor: 6.216

Review 6.  The cellular origin for malignant glioma and prospects for clinical advancements.

Authors:  Hui Zong; Roel G W Verhaak; Peter Canoll
Journal:  Expert Rev Mol Diagn       Date:  2012-05       Impact factor: 5.225

Review 7.  Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis.

Authors:  Akshitkumar M Mistry; Andrew T Hale; Lola B Chambless; Kyle D Weaver; Reid C Thompson; Rebecca A Ihrie
Journal:  J Neurooncol       Date:  2016-09-19       Impact factor: 4.130

8.  Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma?

Authors:  Tejpal Gupta; Vimoj Nair; Siji Nojin Paul; Sadhana Kannan; Aliasgar Moiyadi; Sridhar Epari; Rakesh Jalali
Journal:  J Neurooncol       Date:  2012-05-04       Impact factor: 4.130

Review 9.  Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.

Authors:  Pedro R Lowenstein; Maria G Castro
Journal:  Clin Immunol       Date:  2017-07-15       Impact factor: 3.969

10.  Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression.

Authors:  Maxwell Lewis Neal; Andrew D Trister; Sunyoung Ahn; Anne Baldock; Carly A Bridge; Laura Guyman; Jordan Lange; Rita Sodt; Tyler Cloke; Albert Lai; Timothy F Cloughesy; Maciej M Mrugala; Jason K Rockhill; Russell C Rockne; Kristin R Swanson
Journal:  Cancer Res       Date:  2013-02-11       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.